High Outlier
Strength
150 mg/1
Manufacturer
ViiV Healthcare CompanyNDC
49702020318
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2015
Active Ingredients
LAMIVUDINEApproval Type
New Drug (NDA)
FDA Application
NDA020564On Market Since
10/4/2010
Pharmacological Classes
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Nucleoside Reverse Transcriptase Inhibitors
Related Drugs
Same classification
ZIAGEN 20 MG/ML SOLUTION
Brand
49702022248•ViiV Healthcare Company
$0.5865
per ML
INTELENCE 100 MG TABLET
Brand
59676057001•Janssen Products LP
$10.9213
per EA
COMBIVIR TABLET
Brand
49702020218•ViiV Healthcare Company
$14.3948
per EA
EMTRIVA 200 MG CAPSULE
Brand
61958060101•Gilead Sciences, Inc.
$17.4370
per EA
INTELENCE 200 MG TABLET
Brand
59676057101•Janssen Products LP
$24.2861
per EA
VIREAD 300 MG TABLET
Brand
61958040101•Gilead Sciences, Inc.
$40.7318
per EA
BARACLUDE 1 MG TABLET
Brand
00003161212•E.R. Squibb & Sons, L.L.C.
$43.9221
per EA
BARACLUDE 0.5 MG TABLET
Brand
00003161112•E.R. Squibb & Sons, L.L.C.
$44.1865
per EA
EDURANT 25 MG TABLET
Brand
59676027801•Janssen Products LP
$48.1197
per EA
VEMLIDY 25 MG TABLET
Brand
61958230101•Gilead Sciences, Inc.
$51.9338
per EA